The 23-time WTA tournament winner joins Mundipharma to promote exercise and healthy living
Dubai, U.A.E, 18th February 2016 – The twenty three time winning, Danish tennis champion Caroline Wozniacki partnered with Mundipharma and the Women Sports Committee at the Dubai Ladies club to encourage women to pursue their personal goals through exercise and healthy living.
As BETADINE’s® new global Brand Ambassador, Wozniacki shared her personal journey to more than 200 people who attended an event at Dubai Ladies Club. Wozniacki’s message stressed the importance of sustaining a good healthcare plan when it comes to fighting infections and injuries. She encouraged women to have an effective daily regime against infection and injuries and to strive to be responsibly active in everything they do.
“Caroline is a great example of what it takes to be at the forefront of fitness and to succeed. Her skills as a tennis player, a champion and a woman are admirable and we are extremely honoured to partner with her,” commented Dr. Ashraf Allam, Regional Vice President of Mundipharma Middle East and Africa region.
Dr. Allam added that Mundipharma is looking forward to working with Wozniacki as she continues to raise awareness of these important issues and the role of BETADINE in protecting the community against infection.
Wozniacki will use her profile as a world-class athlete to help women as well as the rest of the community fight against the spread of infection. From minor cuts to major infections, BETADINE® products are used and trusted as an antiseptic for more than 50 years, consistently demonstrating strong effectiveness against bacteria, viruses and fungi that cause infections (1* & 3*).
1*-Sibbald RG, Leaoer DJ, Queen D. Iodine Made Easy. Wounds International 2011; 2(2): Available from http://www.woundsinternational.com.
2*-Lachapelle J-M et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. 2013; 10(5): 579–592.
3*-Fleisher W. Povidone-iodine in Antisepsis –State of the Art. Dermatology 1997;195(suppl 2):3-9.
The Mundipharma network of independent associated companies consists of privately owned companies and joint ventures covering the world’s pharmaceutical markets. These companies are committed to bringing to patients the benefits of pioneering treatment options in the core therapy areas of oncology, pain, respiratory, ophthalmology consumer healthcare and rheumatoid arthritis.
For Media Inquiries (Not for publishing)
Shamim Kassibawi, Spread Communications, +971 50 550 3230, Shamim@spreadcomms.com
Patrycja Czoch, Mundipharma
Corporate Communications Manager
Middle East & Africa Region
Tel: + 97 1 4 439 87 77
Mob: +97 1 50 85 12 700
®: BETADINE is a registered trademark of Mundipharma